Balrampur Chini Mills Approves ₹160 Cr Lactogypsum Plant, ₹450 Cr Fund Raise

2 min read     Updated on 25 Apr 2026, 08:41 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Balrampur Chini Mills has approved a ₹160 crore lactogypsum processing plant at Kumbhi, Uttar Pradesh, with production capacity of 76 lakh gypsum boards annually, expected to commence commercial operations by December 2027. The company has also approved a ₹450 crore preferential equity issue with 43% promoter participation and ₹200 crore NCD issuance to support expansion initiatives, while revising its PLA project capex to ₹3,080 crores.

powered bylight_fuzz_icon
38487421

*this image is generated using AI for illustrative purposes only.

Balrampur Chini Mills has approved the establishment of a Lactogypsum Processing Plant at Kumbhi, Uttar Pradesh, with an estimated investment of up to ₹160 crores. The company has also approved a preferential issue of equity shares worth ₹450 crores to support its expanding capital expenditure plans and strategic initiatives.

Lactogypsum Processing Plant Development

The proposed facility will manufacture gypsum boards using lactogypsum, a by-product of the company's upcoming Polylactic Acid (PLA) project. The plant is expected to have a production capacity of approximately 76 lakh gypsum boards per annum, with commercial production expected to commence by December 2027.

Plant Specifications: Details
Investment: Up to ₹160 crores
Location: Kumbhi, Uttar Pradesh
Capacity: 76 lakh gypsum boards per annum
Commercial Production: December 2027
Raw Material: Lactogypsum from PLA operations

Ms. Avantika Saraogi, Executive Director at BCML, stated that the proposed fund raise aims to support the company's next phase of expansion and enable investments in strategic initiatives such as the upcoming gypsum processing plant at Kumbhi.

Comprehensive Funding Strategy

The board has approved a preferential issue of equity shares aggregating to approximately ₹450 crores, subject to shareholders approval. The capital infusion is aimed at strengthening the company's balance sheet and supporting upcoming expansion initiatives, with promoters participating at approximately 43 percent.

Funding Components: Amount (₹ crores)
Preferential Share Issue: 450
NCD Issue Approval: 200
Total Funding Capacity: 650
Promoter Participation: 43%

Additionally, the board has authorized the issuance of Non-Convertible Debentures (NCDs) up to ₹200 crores in one or more tranches, further enhancing financial flexibility for future growth opportunities.

Revised PLA Project Capital Expenditure

The company has revised the capital expenditure for its Polylactic Acid (PLA) project to approximately ₹3,080 crores, reflecting updated project requirements and cost escalations from the original ₹2,850 crores.

Project Details: Specifications
Revised Project Capex: ₹3,080 crores
Original Project Capex: ₹2,850 crores
Cost Escalation: ₹230 crores
Project Capacity: 80,000 tonnes per annum

Mr. Vivek Saraogi, Chairman & Managing Director, BCML, emphasized that the company continues to take a calibrated approach towards growth, with a clear focus on strengthening its integrated business model. He noted that the continued participation from promoters in the proposed fund raise reflects their commitment to these initiatives and confidence in the long-term value creation potential of the business.

Strategic Project Portfolio

The comprehensive funding structure supports the company's ambitious expansion plans across multiple strategic initiatives, demonstrating commitment to sustainable growth and diversification into value-added products.

Strategic Projects: Investment (₹ crores)
PLA Project (Revised): 3,080
Lactogypsum Processing Plant: 160
Total Project Investment: 3,240
Available Funding: 650

Balrampur Chini Mills operates as one of India's largest integrated sugar companies with ten sugar factories in Uttar Pradesh, aggregate sugarcane crushing capacity of 80,000 TCD, distillery operations of 1,050 KLPD, and cogeneration operations of 175.7 MW.

Historical Stock Returns for Balrampur Chini Mills

1 Day5 Days1 Month6 Months1 Year5 Years
-4.48%+6.69%+9.00%+10.08%-12.49%+94.02%

How will the gypsum board market competition affect BCML's pricing strategy when production begins in December 2027?

What impact could potential delays in the PLA project have on the lactogypsum supply chain for the processing plant?

Will BCML consider expanding beyond gypsum boards to other construction materials using similar by-product integration strategies?

like19
dislike

Balrampur Chini Mills Grants 12,777 Employee Stock Appreciation Rights Under ESAR 2023

1 min read     Updated on 24 Apr 2026, 06:04 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Balrampur Chini Mills Limited has granted 12,777 Employee Stock Appreciation Rights (ESARs) to eligible employees under its ESAR 2023 plan at ₹541.55 per unit. The ESARs feature a 4-year vesting period followed by a 4-year exercise window, with implementation conducted in full compliance with SEBI regulations.

powered bylight_fuzz_icon
38489987

*this image is generated using AI for illustrative purposes only.

Balrampur Chini Mills Limited has officially granted Employee Stock Appreciation Rights (ESARs) to eligible employees under its ESAR 2023 plan. The company informed stock exchanges on April 23, 2026, in compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015 and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

ESAR Grant Details

The company has granted 12,777 ESARs under the BCML Employees Stock Appreciation Rights Plan 2023. Each ESAR has been priced at ₹541.55, with a structured vesting and exercise framework designed to align employee interests with long-term company performance.

Parameter Details
Scheme ESAR 2023/Plan
Type of Option Employee Stock Appreciation Rights (ESARs)
Number of ESARs Granted 12,777
ESAR Price per Unit ₹541.55
Vesting Period 4 years
Exercise Period 4 years from vesting date

Implementation Framework

The ESARs will vest over a period of four years, providing employees with a four-year exercise window from the date of vesting. The quantity of equity shares to be allotted against each ESAR will be determined according to the provisions outlined in the ESAR 2023 plan.

Regulatory Compliance

The grant has been executed in accordance with applicable SEBI regulations governing share-based employee benefits and sweat equity. The formal intimation was signed by Manoj Agarwal, Company Secretary & Compliance Officer, and submitted to both NSE (Symbol: BALRAMCHIN) and BSE (Scrip Code: 500038) for record purposes.

This employee stock appreciation rights program demonstrates the company's commitment to employee retention and performance-based compensation aligned with shareholder value creation.

Historical Stock Returns for Balrampur Chini Mills

1 Day5 Days1 Month6 Months1 Year5 Years
-4.48%+6.69%+9.00%+10.08%-12.49%+94.02%

How will the ESAR program impact Balrampur Chini Mills' talent retention rates and ability to attract skilled professionals in the competitive sugar industry?

What performance metrics or stock price targets must be achieved for employees to maximize the value of their ESARs over the 4-year vesting period?

Could this employee incentive program signal Balrampur Chini Mills' preparation for major expansion or strategic initiatives requiring enhanced workforce commitment?

like16
dislike

More News on Balrampur Chini Mills

1 Year Returns:-12.49%